Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people.

@article{Solmi2019DisparitiesIC,
  title={Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people.},
  author={Marco Solmi and Joseph Firth and Alessandro Miola and Michele Fornaro and Elisabetta Frison and Paolo Fusar-Poli and Elena Dragioti and Jae Il Shin and Andr{\'e} Ferrer Carvalho and Brendon Stubbs and Ai Koyanagi and Stephen R Kisely and Christoph U. Correll},
  journal={The lancet. Psychiatry},
  year={2019}
}
Colorectal cancer Outcomes in people with Severe Mental Illness Cohort (COSMIC): a protocol for an Australian retrospective cohort using linked administrative data
TLDR
This study aims to compare participation in Australia’s National Bowel Cancer Screening Programme (NBCSP) in those with SMI and those in the general population, and investigate treatment pathways after diagnosis to determine whether treatment variations could explain differences in CRC mortality.
Cancer Screening Among Adults With and Without Serious Mental Illness
TLDR
Clinicians identified 5 themes that may help explain the lower rates of cancer screening in persons with SMI: access to care, available support, prioritization of other issues, communication, and patient concerns.
The overall and sex- and age-group specific incidence rates of cancer in people with schizophrenia: a population-based cohort study
TLDR
People with schizophrenia do not have a higher overall incidence of cancer than people in the general population, however, there are significant differences in the risk of specific cancer types overall and by sex calling for efforts to develop disease-specific prevention programmes.
Cancer and schizophrenia
TLDR
Patients with schizophrenia are at increased risk of dying of cancer and of several specific types of cancer, which can be reduced if the price of tobacco is increased, if smoking cessation programmes are offered systematically, screening programs better implemented in this highly vulnerable group, and if procedures to facilitate access to early diagnosis and effective treatment are implemented.
Mortality in people with schizophrenia: a systematic review and meta‐analysis of relative risk and aggravating or attenuating factors
TLDR
A systematic review and random‐effects meta‐analysis of prospective and retrospective, nationwide and targeted cohort studies assessing mortality risk in people with schizophrenia versus the general population or groups matched for physical comorbidities or groups with different psychiatric disorders moderated larger natural‐cause mortality risk.
Excess mortality from cancer in people with mental illness—Out of sight and out of mind
TLDR
In a large systematic review and metaanalysis of 47 publications on 4.7 million individuals, screening for breast, cervical, prostate and overall cancer was significantly less frequent in people with MI than the general population.
Schizophrenia and cancer.
TLDR
The literature makes recommendations about surmounting barriers and also offers suggestions with respect to support and palliative care in advanced stages of cancer, including examples of effective collaboration between mental health and cancer care specialists.
...
...

References

SHOWING 1-10 OF 54 REFERENCES
Cancer-related mortality in people with mental illness.
TLDR
Although incidence is no higher than in the general population, psychiatric patients are more likely to have metastases at diagnosis and less likely to receive specialized interventions, which may explain their greater case fatality and highlights the need for improved cancer screening and detection.
A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?
TLDR
In light of the potential for second-generation antipsychotic medications to further adversely influence mortality rates in the decades to come, optimizing the general health of people with schizophrenia warrants urgent attention.
Mammography Among Women With Severe Mental Illness: Exploring Disparities Through a Large Retrospective Cohort Study.
TLDR
Findings can inform efforts to improve breast cancer screening among women with severe mental illness, such as targeted outreach to population subsets and colocation of primary care services in mental health treatment settings.
Excess Cancer Mortality in Psychiatric Patients
TLDR
People with mental illness in Nova Scotia have increased mortality from cancer, which cannot always be explained by increased incidence.
Breast and cervical cancer screening for women with mental illness: patient and provider perspectives on improving linkages between primary care and mental health
TLDR
Challenges to accessing and providing breast and cervical cancer screening for women with mental illness are explored and communication between primary care and mental health providers was noted as a key area for intervention to enhance screening.
Cancer care for individuals with schizophrenia
TLDR
Comprehensive data on overall and cancer‐specific mortality for individuals with schizophrenia is summarized and specific disparities across the cancer care continuum of screening, diagnosis, treatment, and end‐of‐life care are reviewed.
Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta‐analysis
TLDR
The T2DM prevalence was consistently elevated in each of the three major diagnostic subgroups compared to matched controls, and was higher in patients prescribed antipsychotics, except for aripriprazole and amisulpride.
...
...